Fresenius Kabi in talks to buy Akorn

By Gareth Macdonald

- Last updated on GMT

iStock/macgyverhh
iStock/macgyverhh

Related tags U.s. securities and exchange commission Fresenius kabi

Akorn Inc is in takeover talks with German injectable drug specialist Fresenius SE & Co. KGaA.

The US generic drug manufacturer confirmed the talks in a US Securities and Exchange Commission (SEC) filing​ today.

Similarly, Fresenius said​ discussions are ongoing.

A spokesman for the German firm told us "Fresenius Kabi is currently in discussions with Akorn, Inc. concerning a potential acquisition​."

He declined to comment further.

Related news

Show more

Related products

show more

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us

Products

View more

Webinars